Ahammune
4 known investors
Ahammune develops small-molecule therapeutics for chronic skin diseases, with a lead program targeting vitiligo by restoring deregulated cellular pathways in the skin. The company focuses on dermatology drug discovery.
BiotechDeep TechDigital Health
Investors · 4
Frequently asked questions
- What does Ahammune do?
- Ahammune develops small-molecule therapeutics for chronic skin diseases, with a lead program targeting vitiligo by restoring deregulated cellular pathways in the skin. The company focuses on dermatology drug discovery.
- Who are Ahammune's investors?
- Ahammune's investors include Capital2B, Colossa Ventures, Ideaspring Capital, pi Ventures.